At a glance
- Originator Abbott Laboratories
- Class Antihormones; Peptides
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female infertility; Male infertility; Prostate cancer
Most Recent Events
- 31 Dec 2010 Discontinued - Phase-I for Female infertility in USA (unspecified route)
- 31 Dec 2010 Discontinued - Phase-I for Male infertility in USA (unspecified route)
- 31 Dec 2010 Discontinued - Phase-I for Prostate cancer in USA (unspecified route)